Home » Topics » Regulatory

Regulatory
RSS

Raloxifene for inhibition of vascular smooth muscle cell migration

Jan. 23, 1997

Glaxo Wellcome claims new formulation of anxiolytic agent

Jan. 23, 1997

Asta seeks rights to impotency Rx

Jan. 21, 1997

Olopatadine studied for allergic conjunctivitis

Jan. 20, 1997

Mochida claims new formulation for ulinastatin

Jan. 20, 1997

Takeda claims new approach to diabetes Rx

Jan. 20, 1997

FDA approves topical acne treatment

Jan. 17, 1997

New treatment option for HIV-infected children

Jan. 17, 1997

New impotence Rx now available in U.S.

Jan. 16, 1997

Approval sought for Androtest-SL

Jan. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.